A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19
Sumathi Sivapalasingam, David J. Lederer, Rafia Bhore, Negin Hajizadeh, Gerard Criner, Romana Hosain, Adnan Mahmood, Angeliki Giannelou, Selin Somersan-Karakaya, Meagan O’Brien, Anita Boyapati, Janie Parrino, Bret Musser, Emily Labriola-Tompkins, Divya Ramesh, Lisa A. Purcell, Daya Gulabani, Wendy Kampman, Alpana Waldron, Michelle Ng Gong, Suraj Saggar, Steven J. Sperber, Vidya Menon, David K. Stein, Magdalena E. Sobieszczyk, William Park, Judith A. Aberg, Samuel M. Brown, Jack A. Kosmicki, Julie E. Horowitz, Manuel A. Ferreira, Aris Baras, Bari Kowal, A. Thomas DiCioccio, Bolanle Akinlade, Michael C. Nivens, Ned Braunstein, Gary Herman, George D. Yancopoulos, David M. Weinreich, for the Sarilumab-COVID-19 Study Team
doi: https://doi.org/10.1101/2021.05.13.21256973
Sumathi Sivapalasingam
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D.David J. Lederer
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D., M.S.Rafia Bhore
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ph.D.Negin Hajizadeh
2Institute for Clinical Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York
M.D., M.P.H.Gerard Criner
3Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania
M.D., F.A.C.P., F.A.C.C.PRomana Hosain
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D., M.P.H.Adnan Mahmood
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D.Angeliki Giannelou
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D.Selin Somersan-Karakaya
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D.Meagan O’Brien
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D.Anita Boyapati
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ph.D.Janie Parrino
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D.Bret Musser
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ph.D.Emily Labriola-Tompkins
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
B.A.Divya Ramesh
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ph.D.Lisa A. Purcell
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ph.D.Daya Gulabani
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.S., M.B.A.Wendy Kampman
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D.Alpana Waldron
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.S.Michelle Ng Gong
4Montefiore – Moses, Bronx, New York
M.D.Suraj Saggar
5Holy Name Medical Center, Teaneck, New Jersey
D.O.Steven J. Sperber
6Hackensack Meridian School of Medicine and Hackensack University Medical Center, Hackensack, New Jersey
M.D., F.A.C.P., F.I.D.S.A.Vidya Menon
7NYC Health + Hospitals/Lincoln, Bronx, New York
M.D., F.A.C.P.David K. Stein
8Jacobi Medical Center, Bronx, New York
M.D., F.A.C.P.Magdalena E. Sobieszczyk
9Columbia University, New York, New York
M.D., M.P.H.William Park
10Pulmonary and Sleep Disorder Clinic, Valley Medical Center, Renton, Washington
M.D.Judith A. Aberg
11Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York
M.D.Samuel M. Brown
12Intermountain Medical Center and University of Utah, Salt Lake City, Utah
M.D., M.S.Jack A. Kosmicki
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ph.D.Julie E. Horowitz
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ph.D.Manuel A. Ferreira
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ph.D.Aris Baras
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D., M.B.A.Bari Kowal
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.S.A. Thomas DiCioccio
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ph.D.Bolanle Akinlade
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D., M.B.A., F.A.C.P.Michael C. Nivens
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
Ph.D.Ned Braunstein
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D.Gary Herman
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D.George D. Yancopoulos
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D., Ph.D.David M. Weinreich
1Regeneron Pharmaceuticals, Inc., Tarrytown, New York
M.D.![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Qualified researchers may request access to study documents (including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan) that support the methods and findings reported in this manuscript. Individual anonymized participant data will be considered for sharing once the indication has been approved by a regulatory body, if there is legal authority to share the data and there is not a reasonable likelihood of participant re-identification. Submit requests to https://vivli.org/.
Posted June 19, 2021.
A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19
Sumathi Sivapalasingam, David J. Lederer, Rafia Bhore, Negin Hajizadeh, Gerard Criner, Romana Hosain, Adnan Mahmood, Angeliki Giannelou, Selin Somersan-Karakaya, Meagan O’Brien, Anita Boyapati, Janie Parrino, Bret Musser, Emily Labriola-Tompkins, Divya Ramesh, Lisa A. Purcell, Daya Gulabani, Wendy Kampman, Alpana Waldron, Michelle Ng Gong, Suraj Saggar, Steven J. Sperber, Vidya Menon, David K. Stein, Magdalena E. Sobieszczyk, William Park, Judith A. Aberg, Samuel M. Brown, Jack A. Kosmicki, Julie E. Horowitz, Manuel A. Ferreira, Aris Baras, Bari Kowal, A. Thomas DiCioccio, Bolanle Akinlade, Michael C. Nivens, Ned Braunstein, Gary Herman, George D. Yancopoulos, David M. Weinreich, for the Sarilumab-COVID-19 Study Team
medRxiv 2021.05.13.21256973; doi: https://doi.org/10.1101/2021.05.13.21256973
A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19
Sumathi Sivapalasingam, David J. Lederer, Rafia Bhore, Negin Hajizadeh, Gerard Criner, Romana Hosain, Adnan Mahmood, Angeliki Giannelou, Selin Somersan-Karakaya, Meagan O’Brien, Anita Boyapati, Janie Parrino, Bret Musser, Emily Labriola-Tompkins, Divya Ramesh, Lisa A. Purcell, Daya Gulabani, Wendy Kampman, Alpana Waldron, Michelle Ng Gong, Suraj Saggar, Steven J. Sperber, Vidya Menon, David K. Stein, Magdalena E. Sobieszczyk, William Park, Judith A. Aberg, Samuel M. Brown, Jack A. Kosmicki, Julie E. Horowitz, Manuel A. Ferreira, Aris Baras, Bari Kowal, A. Thomas DiCioccio, Bolanle Akinlade, Michael C. Nivens, Ned Braunstein, Gary Herman, George D. Yancopoulos, David M. Weinreich, for the Sarilumab-COVID-19 Study Team
medRxiv 2021.05.13.21256973; doi: https://doi.org/10.1101/2021.05.13.21256973
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2657)
- Dermatology (224)
- Emergency Medicine (401)
- Epidemiology (12254)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4116)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2666)
- Health Policy (1007)
- Hematology (364)
- HIV/AIDS (854)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (440)
- Neurology (3899)
- Nursing (210)
- Nutrition (579)
- Oncology (2038)
- Ophthalmology (586)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6542)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (452)
- Toxicology (54)
- Transplantation (185)
- Urology (166)